If you made any changes in Pure these will be visible here soon.

Research Output 2013 2019

2019

Arterial hypertension in cancer: The elephant in the room

Tini, G., Sarocchi, M., Tocci, G., Arboscello, E., Ghigliotti, G., Novo, G., Brunelli, C., Lenihan, D., Volpe, M. & Spallarossa, P., Apr 15 2019, In : International Journal of Cardiology. 281, p. 133-139 7 p.

Research output: Contribution to journalArticle

Hypertension
Neoplasms
Antineoplastic Agents
Therapeutics
Prehypertension

Identification and management of immune checkpoint inhibitor–related myocarditis: Use troponin wisely

Spallarossa, P., Tini, G., Sarocchi, M., Arboscello, E., Grossi, F., Queirolo, P., Zoppoli, G. & Ameri, P., Sep 1 2019, In : Journal of Clinical Oncology. 37, 25, p. 2201-2205 5 p.

Research output: Contribution to journalComment/debate

Identification and management of immune checkpoint inhibitor–related myocarditis: Use troponin wisely

Spallarossa, P., Tini, G., Sarocchi, M., Arboscello, E., Grossi, F., Queirolo, P., Zoppoli, G. & Ameri, P., 2019, In : Journal of Clinical Oncology. 37, 25, p. 2201-2205 5 p.

Research output: Contribution to journalArticle

Ivabradine in Cancer Treatment-Related Left Ventricular Dysfunction

Sarocchi, M., Arboscello, E., Ghigliotti, G., Murialdo, R., Bighin, C., Gualandi, F., Sicbaldi, V., Balbi, M., Brunelli, C. & Spallarossa, P., Jan 1 2019, In : Chemotherapy. p. 315-320 6 p.

Research output: Contribution to journalArticle

ivabradine
Second Primary Neoplasms
Left Ventricular Dysfunction
Stroke Volume
Fatigue

The Need for Cardiovascular Risk Factor Prevention in Cardio-Oncology

Tini, G., Sarocchi, M., Ameri, P., Arboscello, E. & Spallarossa, P., Apr 1 2019, In : JACC: Heart Failure. 7, 4, p. 367-368 2 p.

Research output: Contribution to journalLetter

2018
docetaxel
Castration
Prednisone
Prostatic Neoplasms
Hypokalemia
Chemotherapy
Anthracyclines
Hodgkin Disease
Stroke Volume
Doxorubicin
Open Access

Potential cardiac risk of immune-checkpoint blockade as anticancer treatment: What we know, what we do not know, and what we can do to prevent adverse effects

Spallarossa, P., Meliota, G., Brunelli, C., Arboscello, E., Ameri, P., Dessalvi, C. C., Grossi, F., Deidda, M., Mele, D., Sarocchi, M., Bellodi, A., Madonna, R. & Mercuro, G., Sep 1 2018, In : Medicinal Research Reviews. 38, 5, p. 1447-1468 22 p.

Research output: Contribution to journalReview article

Neoplasms
Immunotherapy
Therapeutics
Immune Tolerance
Drug Delivery Systems

Serial Troponin for Early Detection of Nivolumab Cardiotoxicity in Advanced Non-Small Cell Lung Cancer Patients

Sarocchi, M., Grossi, F., Arboscello, E., Bellodi, A., Genova, C., Dal Bello, M. G., Rijavec, E., Barletta, G., Rossi, G., Biello, F., Ghigliotti, G., Canepa, M., Mussap, M., Brunelli, C. & Spallarossa, P., Aug 1 2018, In : Oncologist. 23, 8, p. 936-942 7 p.

Research output: Contribution to journalArticle

Troponin
Non-Small Cell Lung Carcinoma
Myocarditis
Disease Progression
Cardiotoxicity
2017

Doxorubicin effect on myocardial metabolism as a prerequisite for subsequent development of cardiac toxicity: A translational 18F-FDG PET/CT observation

Bauckneht, M., Ferrarazzo, G., Fiz, F., Morbelli, S., Sarocchi, M., Pastorino, F., Ghidella, A., Pomposelli, E., Miglino, M., Ameri, P., Emionite, L., Ticconi, F., Arboscello, E., Buschiazzo, A., Massimelli, E. A., Fiordoro, S., Borra, A., Cossu, V., Bozzano, A., Ibatici, A. & 6 others, Ponzoni, M., Spallarossa, P., Gallamini, A., Bruzzi, P., Sambuceti, G. & Marini, C., Oct 1 2017, In : Journal of Nuclear Medicine. 58, 10, p. 1638-1645 8 p.

Research output: Contribution to journalArticle

Fluorodeoxyglucose F18
Doxorubicin
Observation
Hodgkin Disease
Glucose

Identification, prevention and management of cardiovascular risk in chronic myeloid leukaemia patients candidate to ponatinib: an expert opinion

Breccia, M., Pregno, P., Spallarossa, P., Arboscello, E., Ciceri, F., Giorgi, M., Grossi, A., Mallardo, M., Nodari, S., Ottolini, S., Sala, C., Tortorella, G., Rosti, G., Pane, F., Minotti, G. & Baccarani, M., 2017, In : Annals of Hematology. 96, 4, p. 549-558 10 p.

Research output: Contribution to journalArticle

Risk Management
Expert Testimony
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Leukemia, Myeloid, Chronic Phase
Philadelphia Chromosome

Potential cardiac risk of immune-checkpoint blockade as anticancer treatment: What we know, what we do not know, and what we can do to prevent adverse effects

Spallarossa, P., Meliota, G., Brunelli, C., Arboscello, E., Ameri, P., Dessalvi, C. C., Grossi, F., Deidda, M., Mele, D., Sarocchi, M., Bellodi, A., Madonna, R. & Mercuro, G., Dec 28 2017, In : Medicinal Research Reviews.

Research output: Contribution to journalReview article

Neoplasms
Immunotherapy
Therapeutics
Immune Tolerance
Drug Delivery Systems
2013

Enalapril and carvedilol for preventing chemotherapy-induced left ventricular systolic dysfunction

Spallarossa, P., Guerrini, M., Arboscello, E. & Sicbaldi, V., Dec 24 2013, In : Journal of the American College of Cardiology. 62, 25, p. 2451-2452 2 p.

Research output: Contribution to journalLetter